Clinical Trial Update: Posaconazole to Treat Invasive Fungal Infections [Phase 3]

View source ↗

Summary

Phase 3 trial of posaconazole for invasive fungal infections has completed, involving patients with chronic granulomatous disease and Hyper-IgE syndrome. The up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease
• Hyper-ige Syndrome
• Invasive Fungal Infection

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Granulomatous Disease, Chronic, Job's Syndrome | Phase 3 | Status: COMPLETED